Enrichment analysis for discovering biological associations in phenotypic screens.
A phenotypic screen (PS) is used to identify compounds causing a desired phenotype in a complex biological system where mechanisms and targets are largely unknown. Deconvoluting the mechanism of action of actives and identification of relevant targets and pathways remains a formidable challenge. Current methods fail to use the rich information available regarding compounds and their targets in a systematic way for this deconvolution. We have developed an enrichment analysis algorithm to identify targets associated with the desired phenotype in a rigorous data-driven manner using actives and hundreds of thousands of inactives in a PS, as well as results of thousands of available legacy target-based screens in an institution. Our method quantifies association between the PS and targets while reducing sampling bias, which leads to identification of novel targets, additional chemical matter, and appropriate assays. Its use is illustrated using two examples from our laboratories: TRAIL and DNA fragmentation. Enrichment analysis of these PSs is discussed using both biological pathway analysis and known cell biology to demonstrate the value of our method. We believe this enrichment analysis method is an indispensable tool for the analysis of PSs.
Sanofi , 55 Corporate Drive, Bridgewater, New Jersey 08807, United States.
Valery R
VR
Polyakov
Neil D
ND
Moorcroft
Amar
A
Drawid
D000465:Algorithms; D053938:DNA Fragmentation / Q000187:drug effects; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D057166:High-Throughput Screening Assays; D010641:Phenotype; D053221:TNF-Related Apoptosis-Inducing Ligand / Q000378:metabolism
D053221:TNF-Related Apoptosis-Inducing Ligand